Role of intravenous levetiracetam in seizure prophylaxis of severe traumatic brain injury patients

Batool F. Kirmani, Diana Mungall, Geoffrey Ling

Research output: Contribution to journalArticle

Abstract

Traumatic brain injury (TBI) can cause seizures and the development of epilepsy. The incidence of seizures varies from 21% in patients with severe brain injuries to 50% in patients with war-related penetrating TBI. In the acute and sub-acute periods following injury, seizures can lead to increased intracranial pressure and cerebral edema, further complicating TBI management. Anticonvulsants can be used for seizure prophylaxis according to the current Parameters of Practice and Guidelines in a subset of severe TBI patients, and for a limited time window. Phenytoin is the most widely prescribed anticonvulsant in these patients. Intravenous levetiracetam, made available in 2006, is now being considered as a viable option in acute care settings if phenytoin is unavailable or not feasible due to side-effects. We discuss current data regarding the role of intravenous levetiracetam in seizure prophylaxis of severe TBI patients and the need for future studies.

Original languageEnglish (US)
Article number170
JournalFrontiers in Neurology
Volume4 NOV
DOIs
StatePublished - Dec 12 2013
Externally publishedYes

Fingerprint

etiracetam
Seizures
Brain Edema
Phenytoin
Anticonvulsants
Penetrating Head Injuries
Intracranial Pressure
Practice Guidelines
Brain Injuries
Epilepsy
Traumatic Brain Injury

Keywords

  • Epilepsy
  • levetiracetam
  • Phenytoin
  • Seizure prophylaxis
  • Traumatic brain injury

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology

Cite this

Role of intravenous levetiracetam in seizure prophylaxis of severe traumatic brain injury patients. / Kirmani, Batool F.; Mungall, Diana; Ling, Geoffrey.

In: Frontiers in Neurology, Vol. 4 NOV, 170, 12.12.2013.

Research output: Contribution to journalArticle

Kirmani, Batool F. ; Mungall, Diana ; Ling, Geoffrey. / Role of intravenous levetiracetam in seizure prophylaxis of severe traumatic brain injury patients. In: Frontiers in Neurology. 2013 ; Vol. 4 NOV.
@article{b407fd82ebb64df0be5c6df02cf2bf7b,
title = "Role of intravenous levetiracetam in seizure prophylaxis of severe traumatic brain injury patients",
abstract = "Traumatic brain injury (TBI) can cause seizures and the development of epilepsy. The incidence of seizures varies from 21{\%} in patients with severe brain injuries to 50{\%} in patients with war-related penetrating TBI. In the acute and sub-acute periods following injury, seizures can lead to increased intracranial pressure and cerebral edema, further complicating TBI management. Anticonvulsants can be used for seizure prophylaxis according to the current Parameters of Practice and Guidelines in a subset of severe TBI patients, and for a limited time window. Phenytoin is the most widely prescribed anticonvulsant in these patients. Intravenous levetiracetam, made available in 2006, is now being considered as a viable option in acute care settings if phenytoin is unavailable or not feasible due to side-effects. We discuss current data regarding the role of intravenous levetiracetam in seizure prophylaxis of severe TBI patients and the need for future studies.",
keywords = "Epilepsy, levetiracetam, Phenytoin, Seizure prophylaxis, Traumatic brain injury",
author = "Kirmani, {Batool F.} and Diana Mungall and Geoffrey Ling",
year = "2013",
month = "12",
day = "12",
doi = "10.3389/fneur.2013.00170",
language = "English (US)",
volume = "4 NOV",
journal = "Frontiers in Neurology",
issn = "1664-2295",
publisher = "Frontiers Research Foundation",

}

TY - JOUR

T1 - Role of intravenous levetiracetam in seizure prophylaxis of severe traumatic brain injury patients

AU - Kirmani, Batool F.

AU - Mungall, Diana

AU - Ling, Geoffrey

PY - 2013/12/12

Y1 - 2013/12/12

N2 - Traumatic brain injury (TBI) can cause seizures and the development of epilepsy. The incidence of seizures varies from 21% in patients with severe brain injuries to 50% in patients with war-related penetrating TBI. In the acute and sub-acute periods following injury, seizures can lead to increased intracranial pressure and cerebral edema, further complicating TBI management. Anticonvulsants can be used for seizure prophylaxis according to the current Parameters of Practice and Guidelines in a subset of severe TBI patients, and for a limited time window. Phenytoin is the most widely prescribed anticonvulsant in these patients. Intravenous levetiracetam, made available in 2006, is now being considered as a viable option in acute care settings if phenytoin is unavailable or not feasible due to side-effects. We discuss current data regarding the role of intravenous levetiracetam in seizure prophylaxis of severe TBI patients and the need for future studies.

AB - Traumatic brain injury (TBI) can cause seizures and the development of epilepsy. The incidence of seizures varies from 21% in patients with severe brain injuries to 50% in patients with war-related penetrating TBI. In the acute and sub-acute periods following injury, seizures can lead to increased intracranial pressure and cerebral edema, further complicating TBI management. Anticonvulsants can be used for seizure prophylaxis according to the current Parameters of Practice and Guidelines in a subset of severe TBI patients, and for a limited time window. Phenytoin is the most widely prescribed anticonvulsant in these patients. Intravenous levetiracetam, made available in 2006, is now being considered as a viable option in acute care settings if phenytoin is unavailable or not feasible due to side-effects. We discuss current data regarding the role of intravenous levetiracetam in seizure prophylaxis of severe TBI patients and the need for future studies.

KW - Epilepsy

KW - levetiracetam

KW - Phenytoin

KW - Seizure prophylaxis

KW - Traumatic brain injury

UR - http://www.scopus.com/inward/record.url?scp=84889684298&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84889684298&partnerID=8YFLogxK

U2 - 10.3389/fneur.2013.00170

DO - 10.3389/fneur.2013.00170

M3 - Article

AN - SCOPUS:84889684298

VL - 4 NOV

JO - Frontiers in Neurology

JF - Frontiers in Neurology

SN - 1664-2295

M1 - 170

ER -